Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
fluorouracil (efudex) (1 trial)
gimeracil (1 trial)
oteracil (1 trial)
oxaliplatin (eloxatin) (2 trials)
Raltitrexed (Tomudex) (1 trial)
s-1 (1 trial)
tegafur (1 trial)
camrelizumab (1 trial)
fluzoparib (1 trial)
lapatinib (tykerb) (1 trial)
Breast Neoplasms (Phase 1)
Carcinoma (Phase 4)
Carcinoma, Hepatocellular (Phase 4)
Liver Neoplasms (Phase 4)
Neoplasm Metastasis (Phase 4)
Triple Negative Breast Neoplasms (Phase 1)
Trials (4 total)
Trial APIs (10 total)